Washington, D.C. 20549

                                      FORM 8-K

                                   CURRENT REPORT
     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 29, 2002

                            BioMarin Pharmaceutical Inc.
               (Exact name of registrant as specified in its charter)

          Delaware                       000-26727               68-0397820
(State or other jurisdiction of         (Commission            (IRS Employer
 incorporation or organization)         File Number)         Identification No.)

371 Bel Marin Keys Boulevard, Suite 210, Novato, California             94949
(Address of principal executive offices)                              (Zip Code)

Registrant's telephone number, including area code:              (415) 884-6700

                                  Not Applicable
             (Former name or former address, if changed since last report)


Item 5.  Other Events.

     On July 29, 2002, BioMarin Pharmaceutical Inc. (the "Registrant"), together
with its joint  venture  partner  Genzyme  General,  announced the filing of the
final portion of a "Rolling"  Biologics  License  Application with the U.S. Food
and Drug Administration.  The Registrant's press release issued on July 29, 2002
is attached hereto as Exhibit 99.1.

Item 7.           Financial Statements, Pro Forma Financial Statements and

         (a)      Financial Statements of Business Acquired.

                  Not Applicable.

         (b)      Pro Forma Financial Information.

                  Not Applicable.

         (c)      Exhibits.

                  Exhibit 99.1   Press Release of the Registrant dated July 29,


     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                             BioMarin Pharmaceutical Inc.,
                             a Delaware corporation

Date: July 29, 2002                 By: /s/ Fredric D. Price
                                            Fredric D. Price
                                            Chairman and Chief Executive Officer

                                EXHIBIT INDEX

Exhibit No.                Description
-----------               -------------

Exhibit 99.1               Press Release of the Registrant dated July 29, 2002.